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About This Report
In the summer of 2009, The State University of New York embarked on creating the first comprehensive 
strategic plan in the vast system’s sixty-year history. Less than a year later, the University launched 
The Power of SUNY—an ambitious plan that grew out of dozens of intense discussions that took 
place across the state and included voices from all sectors. Over the course of ten months, thousands 
of business owners, elected officials, education experts, community leaders, students, and others 
came out to several town hall-style meetings and events to discuss a common, underlying concern: 
the state’s struggling economy and what could be done—what SUNY could do—to make it flourish 
and create a better quality of life for all New Yorkers.
In the process of putting together The Power of SUNY, six interreliant “Big Ideas” emerged upon 
which the University’s goals for its future—and New York’s future—are built: SUNY and The 
Seamless Education Pipeline, SUNY and Healthier New York, SUNY and an Energy-smart New 
York, SUNY and the Vibrant Community, SUNY and the World, and the subject of this report, SUNY 
and the Entrepreneurial Century.
Research and innovation have long been mainstays of American higher education, but in the 
21st century knowledge creation is no longer enough. Economic growth depends on translating 
knowledge into tangible, measurable benefits, from more patents used to more grants won to more 
jobs created. This shift demands an entrepreneurial mindset, a way of thinking that creates and 
shapes new markets.
The critical components that businesses of all sizes and stages need—knowledge, talent, and 
expertise—can all be found at SUNY. We have $1 billion annually in research expenditures, more 
than 10,000 research projects across the system’s 64 campuses, significant infrastructure, strong 
existing partnerships, and some of the best faculty and students in the world. We must continually 
explore, aggressively, how we can combine and fine-tune our many diffuse pieces to help current 
and future New York companies and address national research gaps.
Because of the SUNY system’s diversity—of areas of expertise, of place, of the make-up of our student 
body and workforce—and sheer magnitude, we are uniquely positioned to serve as New York’s 
strongest economic driver. We take this responsibility seriously and also consider it a tremendous 
privilege. Marrying our core mission, To Learn, To Search, To Serve, with our profound economic 
development capabilities makes for a powerful combination the likes of which, we think, the nation 
has never before seen. We offer this report as one of many steps toward fully realizing our potential 
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Foreword
In coming to New York and SUNY in June 2012, I joined a state and university system with visionary 
leadership unmatched in scope, scale and diversity of talent, infrastructure and innovative thought. 
Together New York and SUNY are charting new paths to economic development and entrepreneurial 
opportunity.
The timing of this study by the SUNY Levin Institute is opportune. Governor Cuomo has set forth 
a comprehensive Innovation Agenda that includes START-UP NY, Innovation “Hot Spots,” the 
New York State Venture Capital Fund and the Innovation New York Network. These programs and 
platforms work together to foster entrepreneurialism and economic growth through public-private 
partnerships that give researchers the tools they need to bring their ideas to market.
START-UP New York will transform SUNY campuses and other university communities across 
the state into tax-free communities for new and expanding businesses. Innovation Hot Spots in all 
regions will help innovators and entrepreneurs grow new companies, invest new funds to support 
start-up enterprises, and establish an Innovation New York Network that connects entrepreneurs 
with investors, customers, and talent from around the State and beyond to “turbocharge” New 
York’s innovation economy.
SUNY’s Chancellor, Nancy Zimpher, has shaped SUNY’s leading role to revitalize New York’s 
economy, bringing forward the power of its sixty-five campuses—each within an hour’s drive 
of every citizen of the State. Indeed the Power of SUNY is a primary engine driving New York’s 
economy.
With that and other key partnerships in place, New York has unlimited and untapped potential. 
New York’s ranking as #2 in the nation in R&D expenditures at its universities is a testament to 
the excellence and energy of its academics in both the public and private sector. Its lower ranking 
of entrepreneurial outcomes from this R&D compared to other states such as California and 
Massachusetts is what gives us the chance to improve.
Thanks to our colleagues at the SUNY Levin Institute, the Entrepreneurship in New York Study gives 
precise focus to this opportunity and instructs us on how best to raise our game and our standing. It 
provides essential data and identifies the unique features of New York’s innovation and investment 
climate on which we need to confidently and actively rely.
Dr. Tim Killeen
President, The Research Foundation for SUNY 
SUNY Vice Chancellor for Research
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I. Introduction to The Entrepreneurship 
in New York Project
This is an auspicious time for innovation and entrepreneurship in the State of New York. 
In his 2013 State of the State speech, Governor Andrew M. Cuomo addressed what con-
tinues to be a significant economic conundrum, i.e., the transfer of innovative technologies 
from academia to start-up companies. “We’re doing the research, we’ve developed the ideas, we 
have the academic institutions: we’re not making the transference to commercialization.” The gov-
ernor established an ambitious statewide innovation agenda to improve New York’s per-
formance in creating new businesses and deriving economic benefit from its vast research 
and development assets. Building on the established Regional Economic Development 
Councils, the governor proposed:
• The formation of ten regional Innovation Hot-Spots;
• A $50 million public fund for innovation-based early stage companies;
• Landmark START-UP NY legislation, aimed at growing new businesses in 
tax-free enclaves on SUNY campuses, as well as other academic institutions in 
the state; and
• Integrating these activities through an Innovation New York Network.
The Entrepreneurship in New York Project (ENY) builds on New York in the World, a 2011 
SUNY Levin Institute study on the impact of globalization on New York City and State. 
This earlier study, conducted with the Center for an Urban Future, catalogued the eco-
nomic evolution of both downstate and upstate New York in the era of globalization 
and provided an understanding of how and where New York State has prospered, and 
where it has not—a challenging presentation of the upstate-downstate divide. The “Road 
Ahead” section recommended a growth strategy for the New Global Economy, built on 
five important dimensions:
• Promote and support entrepreneurship;
• Build upon the state’s R&D assets to expand the Innovation Economy;
• Help more New York businesses export and compete globally;
• View colleges and universities as economic drivers for regional growth; and
• Improve connections between upstate cities and New York City.
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In light of the findings of New York in the World, and the importance of a new state innova-
tion agenda, the goals of the Entrepreneurship in New York Project are to:
• Better understand the realities of innovation and entrepreneurship in New 
York’s cities and regions, as linked to university-based R&D and investing 
patterns;
• Establish a baseline of current entrepreneurial success and potential using 
metrics such as number of companies, regional and sector performance, and 
economic impacts; and
• Detail the formation of innovation-based companies and measure the success 
of current and future initiatives to stimulate the translation of innovation into 
commerce.
Entrepreneurship in New York plans to meet these goals through a series of reports deliv-
ered in sequence. This first report compares and contrasts university-based R&D and 
private investment in innovation. The next report will provide an accurate assessment 
of university-related entrepreneurship in the state. It is intended to serve as a baseline 
against which progress of New York’s innovation agenda can be measured. Follow-up 
reports will help to understand best practices and novel initiatives for establishing start-
ups and supporting their success.
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II. Executive Summary
This first ENY report is focused on understanding venture capital (VC) and academic 
R&D, which have historically been two critical assets in the development of any entre-
preneurial ecosystem, and which relate to important concerns expressed by Governor 
Cuomo in January 2013. In his State of the State speech, the governor cited several “Trou-
bling Tech Transfer Facts” from earlier published papers based on 2007 data.1
New York universities rank second nationally in total research spending with nearly $4B 
spent annually; California ranks first with $6.5B.2 However,
• New York attracts only 4% of the nation’s VC investment while California 
attracts 47%;
• New York’s colleges incubate fewer new companies, with 35 start-ups launched 
in 2007, while California schools had 58 and Massachusetts’s schools had 60; 
and
• New York is home to fewer fast-growing technology companies, with only 11 
on the Deloitte Technology Fast 500 List, as compared with California’s 169 and 
Massachusetts’s 46.
Since 2007, there has been a significant enhancement in the entrepreneurial ecosystem 
and investment climate in New York City. But for most of New York State, the situation 
is not much improved and the message is unfortunately still unchanged in 2013. NYS 
continues to lead nationally for academic research but lag nationally for entrepreneurial 
performance and investment dollars relative to California and Massachusetts. Speaking 
on this disparity between research and commercialization, Cuomo stated, “That gap is 
what we have to fix.”
In this report we present and examine financial data relevant to understanding the pat-
terns of innovation, investment, and entrepreneurship in New York:
Section III: Venture Capital Investing Patterns. California leads all states by far, including 
New York, in the management of venture capital and in received venture investments. In 
recent years, New York has garnered progressively more investments but has been chal-
lenged to close in on the order of magnitude lead that California has had and continues 
to enjoy.
Section IV: What Interests Investors. Venture investors have historically invested broad-
ly, but increasingly now focus on Internet opportunities. That interest has intensified in 
recent years, and is especially pronounced in New York where recent investing has been 
almost exclusively focused on Internet, mobile, and other digital businesses. This is in 
stark contrast to comparative states of California and Massachusetts, which demonstrate 
more balanced investments across many different sectors and fields.
1 “Venture Capital and Seed Activity in New York State”, by Excell Partners, Feb and May 2009, and 
“Governor’s Task Force on Diversifying the New York State Economy through Industry-Higher Education 
Partnership”, Dec 2009.
2 National Science Foundation (NSF) Higher Education Research and Development (HERD) Report, 2007.
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Section V: Venture Investing in New York. Venture investing in New York State is bifur-
cated dramatically along geographic lines. While New York City is basking in a significant 
uptick in start-up capital, venture investing in upstate New York is almost non-existent. 
This has severe consequences on the formation of a robust ecosystem for building new 
businesses.
Section VI: Academic R&D Expenditures. New York is a strong and consistent #2 nation-
ally behind California in university-based R&D expenditures. Academic assets are bal-
anced across the state. Nearly every region in New York has an opportunity to leverage 
its university-based assets to create start-ups, that is, if capital and talent are available to 
launch new companies. Academic researchers, however, are focused on the hard sciences, 
i.e., industries that appear to be losing favor with VCs, particularly in New York State.
Section VII: Mismatched Interests. When the data for venture investing in New York 
are juxtaposed with the data for university-based R&D, one observes a significant mis-
alignment between the interests of investors (in digital technologies) and of the academic 
research community (in the hard sciences). This could be a significant obstacle to the com-
mercialization of university technologies and the creation of innovation-based spin-outs 
in New York. We are unaware of any other report that has acknowledged this situation. 
The data will show how dramatic this misalignment is in New York, as compared to Cali-
fornia and Massachusetts, and especially as it relates to the life sciences.
This unique profile of academic research and private investment in New York presents a 
challenge, offers an opportunity, and prompts some thoughts for consideration.
A Challenge: The governor has posed a challenge and initiatives to improve technology 
transfer and accelerate the commercialization of university-based innovation. Accelera-
tion will be difficult without a near, knowledgeable, and engaged cadre of investors who 
are interested in the hard sciences and willing to help create and grow businesses built 
on Life and Physical Science research. In New York State, the wider difference in interest 
between investors and academic researchers, compared with California and Massachu-
setts, poses a significant challenge. Fixing the mismatched interests between investors and 
researchers may require creative actions, for instance, engaging the investor communities 
in California and Massachusetts.
An Opportunity: New York City VCs and angels are capitalizing on the city’s emerging 
strengths in “soft tech.” This trend is beneficial for the NYC economy, entrepreneurial 
community, and investor returns. The success of the “NYC paradigm” in growing entre-
preneurial businesses over the past five years, without great contribution from university 
R&D, should be explored for its potential economic benefit. START-UP NY may offer the 
chance for many kinds of university-business alliances to form upstate, based on creative 
and commercial services and IT applications. Opportunities to design mutually beneficial 
partnerships to grow innovative businesses upstate based on this model should be con-
sidered.
For Consideration: The alignment and adequacy of capital and R&D, in both type and 
quantity, is essential to the success of an innovation economy. These investment streams 
operate best when matched and balanced regionally, and in New York’s case, across 
regions. This balance is currently not observed in New York and the situation must be 
understood and addressed in order to develop an enduring and successful innovation 
agenda that serves all parts of the state.
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Note: Unless otherwise indicated, all venture capital data in this report is derived from the National 
Venture Capital Association (NVCA) Annual Reports 2008-2013 and www.pwcmoneytree.com. 
All data pertaining to academic R&D is derived from the National Science Foundation (NSF) 
Higher Education Research and Development (HERD) Reports from 2008-2011. A detail method-
ology section is provided in Appendix B.
III. Venture Capital Investing Patterns
There is wide agreement among policy makers on the importance of entrepreneurial companies to eco-
nomic growth and well-being. Venture capital (VC) is a major driver of that entrepreneurial economy. 
The nation continues to look to this sector for job creation, economic development, better healthcare, 
cleaner technology, and a faster, better, and more secure internet. (National Venture Capital Associa-
tion Yearbook 2013)
In today’s economy, there is wide agreement by policy makers on the importance of entrepre-
neurial companies, but often times it seems that policy makers do not understand how entrepre-
neurship happens, especially for innovation-based companies. Significant capital is required, 
in stages, to launch these companies and successfully position their high-tech products in the 
market. Generally the more sophisticated the technical basis of a company, the more venture 
capital is required. Because of the high sophistication level of university-based research in the 
hard sciences, venture capital is vitally important to its translation into commercial ventures.
It behooves stakeholders to understand how much venture capital is available and being invest-
ed in New York State and what industries the VCs are focused on. To provide context at the 
state level, this study starts by looking at VC investing at the national level.
National VC Investments. Figure 2.1 below shows national VC investments for the last five 
years.
Figure 2.1: National Venture Capital Investment, 2008-2012 
As evidenced in 2009, there was a bit of a dip in venture capital after the market crash, but 
investing has recovered, and in general has held fairly steady nationally in the $20-30 billion 
range. Note however, that unlike academic R&D funding, which will be discussed in a later sec-
tion of this report, and where the government consistently increases spending year after year, 
VC funding is subject to market variability.
A bit unusual is the fact that venture capital is highly concentrated in very few states, primar-
ily California, Massachusetts, and New York. In an attempt to profile these states, Figure 2.2 
$M
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again shows overall U.S. investing for the last five years in blue juxtaposed with bars that 
represent percent of total for these states of interest.
Figure 2.2: Top Three States for VC Investments, 2008-2012
It is obvious from this figure that California dominates the industry. Every year, regard-
less of the specific amount invested, or whether the market waxes or wanes, California 
receives at or over 50% of the nation’s venture capital, and as the bars indicate, the trend 
has been upwards in the last five years. Every year, more and more capital ends up (per-
centage-wise) in California.
Massachusetts ranks second in the nation for VC investments, holding steady at about 
11%. New York ranks third but at a fraction of California’s total. In the last five years, 
New York has trended slightly upwards. This allows us to update one of the governor’s 
Troubling Tech Transfer Facts:
• In 2007, New York attracted only 4% of the nation’s VC investments while 
California attracted 47%.
• In 2012, New York attracted 7% of the nation’s VC investments while California 
attracted 53%.
While many New Yorkers are taking great pride in the 2012 uptick, New York is still 
hugely behind California as it relates to venture capital.
Not shown on this graph are the other top states. Texas and Washington almost always 
rank either as fourth or fifth in the nation but with a very small percent of 2-3% of the 
national total each. All other 45 states share the remainder, meaning that they each receive 
0-1% of whatever is left.
Investments vs. Deals. Figure 2.3 summarizes and averages out the VC investments for 
the top three states over the last five years. California received about $13B each year for an 
$M
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average of 51% of the national total, compared to New York, which received about $1.7B 
each year for an average of 6% of the national total.
State Average Investment($M) 2008-2012





US Total $25,954 100%
 Figure 2.3: VC Investments for Top Three States
Relative to numbers of transactions, or deals, as shown in Figure 2.4, California saw about 
1,500 VC deals each year for an average of 41% of the total, compared to New York, which 
saw nearly 300 deals each year for an average of 8% of the total.




US Total 3,720 100%
Figure 2.4: VC Deals for Top Three States
If, per state, average investments in Table 2.3 are divided by average number of deals in 
Table 2.4, the resulting quotient is average deal size. Figure 2.5 shows that the average 
deal size in the U.S. is $6.9M. Average deal size is significantly higher in California at 
$8.7M per deal, Massachusetts is at $7.3M per deal, and NY is below the national average 
at $5.7M per deal.





Figure 2.5: VC Deal Size for Top Three States
Deal size quantities could be related to the types of deals that are being made in these 
regions. As will be seen in the next section, most of the New York deals are in digital 
technologies (IT, software, media) and those deals are generally not as capital intensive 
as many of the Life and Physical Science deals that are being transacted in California and 
Massachusetts.
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Capital under Management. The data already presented refers to venture capital that is 
being received by a state or region on an annual basis. This is not the same as capital 
under management, i.e., how much money VCs have available to deploy.




US Total $195,280 100%
Figure 2.6: Capital under Management, 2008-2012
As shown in Figure 2.6 above, California, Massachusetts, and New York are again the top 
three states for capital under management. As a side note, the financial collapse on Wall 
Street in 2008 caused a 30% drop in capital under management in the U.S. California and 
Massachusetts were somewhat affected but the worst hit was New York, where inves-
tors saw a 50% drop. Between 2003 and 2007, New York investors averaged $33B under 
management. By 2008-2012, it was down to $18B. This drop could mean that, moving 
forward, VCs will be trying to get higher returns with less money and possibly keeping 
their monies closer to home. That possibility actually suggests a good question: Do VCs 
typically invest close to home?
In-State Investing. The first column of Figure 2.7 shows average capital deployed annu-
ally by-state. The second column shows average capital that remained in-state. And the 
final column shows the average percent that remained in-state.
State Average Capital Deployed Annually by State ($M) 2008-2012
Avg Capital that Remained In-State 
Annually ($M) 2008-2012
Avg % that Remained 
In-State 2008-2012
CA $8,569 $6,103 71%
MA $2,569 $871 34%
NY $2,080 $351 17%
 Figure 2.7: In-State Investing, 2008-2012
California VCs kept 71% in-state, investing only 6% in Massachusetts, 4% in New York, 
and 19% in the rest of the world. It appears that California VCs primarily support Califor-
nia entrepreneurs or entrepreneurs who move to California.
Massachusetts VCs invested 34% in-state, investing a matching 34% in California, 8% in 
New York, and dispersing 24% to the rest of the world.
New York VCs only invested 17% in-state and sent 83% out of state. While that is not great 
news for start-up companies in New York State, it is better than previously reported. In 
papers based on 2007 data,3 it was noted that New York VCs were only investing 9% in-
state and 91% out-of-state. These current numbers represent a significant improvement—
but not for upstate. As later data will show, “in-state” investing really means in or around 
New York City, while upstate New York continues to starve for investment capital.
Of the 83% sent out of state, New York VCs continue to be very generous to California: 
39% of New York monies leave the east coast for the west coast because that is possibly 
3 “Venture Capital and Seed Activity in New York State,” by Excell Partners, Feb and May 2009.
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where the best deals are. Massachusetts receives 10%, and 34% of the monies go to other 
states and countries.
Investing by Stage, Nationally. It is also important to look at investments by stage of 
development, especially since there has been a notable change in investing trends/pat-
terns over the last decade. Going back a decade in time, the statistics show that VCs clearly 
had a preference for investing “later.” Just under 40% of all investing was in later stage 
companies; just under 40% in expansion stage companies; just under 20% in early stage 
companies; and only about 4% in seed stage. This pattern was still true in 2008.
However, the bars in Figure 2.8 show a notable increase in early stage investing to the 
point where it’s nearly an equal third with expansion and later stage.
Figure 2.8: National Investments by Development Stage, 2008-2012
Seed stage investing remains at about 3% of the total, trending downward. The data indi-
cate that seed investing is of lesser interest to VCs. Lack of seed funding for start-up com-
panies has historically been and continues to be a major problem nationally, especially 
for hard science companies requiring considerable sums to successfully pass through the 
“Valley of Death.”4
Section Summary. The data in this section can be summarized as follows. While venture 
capital is subject to market variability, it has remained between $20-30B for the last five 
year. It is highly concentrated in three states—California, Massachusetts, and New York—
with California dominating the other states by an order of magnitude. Not only does Cali-
fornia lead (by far) in the amount of venture capital it receives annually, but its percent of 
the national total increases every year. It also dominates (by far) in the amount of venture 
capital under management. Further, California VCs invest close to home: a remarkable 
71% of the capital deployed by California VCs remains in-state. Possibly Californians VCs 
believe/recognize that the entrepreneurial culture that best favors a high ROI is in their 
4 “Venture Capital and Seed Activity in New York State,” by Excell Partners, Feb and May 2009.
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own backyard. Also, the deal size in California is larger than the average deal size in the 
U.S., including in Massachusetts and New York.
Massachusetts is consistently between California and New York, but actually its numbers 
are closer to New York’s than California’s. New York is consistently coming in third based 
on the criteria used here. Although showing some recent signs of improvement, New York 
is still seriously trailing California.
The only good news for start-up companies is that VCs have started investing more at the 
early stage again (but still not seed), as opposed to previous years where the focus was 
heavily on expansion and later stage investing.
The reader should now have a good foundational understanding of venture capitalists, 
where they are, how much money they have, and how much they deploy. But there has 
been no information provided yet regarding their investing preferences relative to indus-
try. Are they interested in Life and Physical Sciences, i.e., the hard sciences? Or are they 
interested in Information Technology and Creative & Commerce, i.e., digital technologies?
Loosely defining venture investments as high-tech has done a disservice to an accurate 
understanding of what VCs really invest in. A dissection of the phrase “high-tech” is 
proposed in Figure 2.9. High-tech can be divided into two very broad categories of the 
Hard Sciences and Digital Technologies. The Hard Sciences can be further subdivided 
into Life Sciences and Physical Sciences. Digital Technologies can be further subdivided 
into Information Technologies and what will here be called Creative & Commerce. This 
latter category combines many application and service sectors such as media, entertain-
ment, finance, education, retail, etc. These four categories include the 16 specific indus-
tries defined by the National Venture Capital Association (NVCA) as shown in the gray 
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Figure 2.9: Defining and Grouping Industries
It will also be important shortly to consider how much VC activity is Internet related. But 
the Internet is really not a single industry; rather, it is a classification that spans the spec-
trum of industries. Therefore each industry category has been tagged with a value that 
indicates the percent of investable businesses in that category that are “Internet related.” 
For example, 97% of all investable IT companies are offering technologies and services 
that are Internet-related.
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Armed with this terminology and categorization, the authors and readers are equipped 
for the next section to explore the kinds of high-tech opportunities that VCs are pursuing 
most aggressively.
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IV. What Interests Investors
Historical View. This section starts with a big picture, historical view of VC investing, 
because it is important to note that VCs have long had a fascination or a particular interest 
in the Internet.
Figure 3.1 extends all the way back to 1985, before there was an Internet. Note that prior 
to 1985, VC activity was modest and the translation of academic research was barely 
a thought in anyone’s mind. But in 1980, the U.S. Congress passed the Bayh-Dole Act, 
which allowed for the commercialization of federally funded research. It was in the years 
following that universities slowly started establishing tech-transfer offices, and VCs start-
ed taking an interest in the very sophisticated technologies that were coming out of the 
universities. Of course, the genesis of all this was in Boston and Silicon Valley. The life sci-
ences (biotech) and physical sciences (semiconductors) were areas of significant interest 
to the VCs at least from 1985 to 1995. But then came the Internet.
Figure 3.1: 30 Year Trends in VC Investing
Internet-Related Investments. Figure 3.2 shows Internet-related investments from 1995 
to 2012, and the profile should look familiar. VCs started investing in the Internet around 
1995, and their fascination with Internet opportunities has literally shaped the profile of 
their investing patterns. In fact, the excitement over the Internet caused an overly zealous 
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investing spree resulting in the dot-com and telecommunications bubble in the year 2000. 
Over $100B was invested, and 80% of that was in Internet-related opportunities.
Figure 3.2: 20 Year Trends in Internet Investing
Certainly after the bubble burst, things calmed down a bit, but since then, software and IT 
services have continued as the largest industry sectors for VC investing.
Investing by Industry. With that historical perspective, the study is refocused back to the 
last five years and recent investing trends, this time exploring the four primary industry 
sectors defined in the previous section:
Digital Technologies
• Information Technology






Investing in Information Technology and Creative & Commerce over the last five years 
is shown in Figure 3.3, while Life and Physical Science investing is shown in Figure 3.4.
Figure 3.3: VC Investments in IT and Creative & Commerce, Nationally, 2008-2012
Figure 3.4: VC Investments in Life and Physical Sciences, Nationally, 2008-2012
There seems to be a pattern: Investing in IT and Creative & Commerce has been increas-
ing in recent years, and investing in the Life and Physical Sciences has been decreasing. 
Specific numbers for most recent investing in 2012 show that 40% of all investments went 
to IT, another 16% to Creative & Commerce, 26% to Life Sciences, and 18% to Physical 
Sciences.
While not shown here, a look at the number of deals brokered in these industries would 
indicate an even more obvious pattern of “digital domination.” In 2012, 44% of all deals 
were IT, another 16% were Creative & Commerce, 22% were Life Sciences, and 18% were 
Physical Sciences.
Clean Tech Trends. Given the decreasing interest in the physical sciences, some might 




been a lot of interest and support for energy lately. Are there any interesting patterns to 
note?
Figure 3.5: Clean Tech Investing, 2008-2012
As shown in Figure 3.5, clean tech is a subset of the physical sciences. It appears that clean 
tech has played a major role in attracting capital to this industry. In 2008-2009, clean tech 
received about half of all investments in the physical sciences. In 2010-2011, clean tech’s 
percentage of total physical science investing appeared to increase, but overall there was 
a significant drop off in interest in the physical sciences in 2012.
The bottom line is that clean tech or energy investing is still not nearly as interesting as IT 
and all the excitement about clean tech does not seem to be manifesting itself heavily in 
VC investing.
More on IT/Internet. Not to belabor the impact of the Internet on VC, but to thoroughly 
understand it, the following should be noted. While the assumption can be made that the 
vast majority of IT/software investments are Internet related, the fact remains that major-
ity might not mean 100%. On the flip side, it can be assumed that the vast majority of Life 
Science deals are not Internet related. However there might indeed be some opportunities 
(like Health IT) that are Internet-related.
So the 2012 NVCA statistics were reviewed for all investments across all industries and it 
was determined (as reported previously in Figure 2.9) that Internet-related opportunities 
constituted:
• 97% of all investments in Information Technology;
• 93% of all investments in Creative & Commerce;
• Possibly somewhat surprising, 31% of all Physical Science investments; and
• Only 5% of all Life Science investments.
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In total, 59% of all investments across all industries were Internet related, and 65% of all 
deals across all industries were Internet related. That only leaves a minority percent of all 
investments and deals that are truly hard science deals that are not Internet related. With 
regard to initial investments to launch companies, the weighting was even more imbal-
anced, with 73% of all dollars (and 74% of all deals) going to support Internet-related 
companies.
Obvious Reasons. After looking at several figures in succession, which obviously indicate 
that VCs have a strong and growing bias toward investing in Internet-related companies, 
the question provoked is Why? That question has some obvious answers.
Internet-related companies tend to be much easier to grow and manage. They are quicker 
to market, lower cost, and lower risk. Often the business ideas are coming from a young 
demographic—there are vast numbers of students in their dorm rooms writing software 
and developing new apps and social networking websites. There is an entire generation 
of students all striving to be the next Mark Zuckerberg. This younger generation has the 
time for Y-combinator, Tech Stars, Start-up Weekend—programs customized for IT and 
the Internet. If VCs have expertise in SW/IT/Internet not the hard sciences, then this is 
where they’ll invest. (The same can be said of angel investors.)
Hard science companies are harder and riskier. Life Science companies in particular are 
very difficult. It can take many years to develop and take a new drug to market. It is very 
costly, high risk, and there are many regulatory hurdles. Technologies are being developed 
by high-level university professors, who are preoccupied with their “day jobs.” They have 
a full teaching load. They are writing grant proposals and monitoring graduate students 
and post-docs in their labs. Pitching business ideas can be difficult for these scientists, and 
due diligence can be complicated for the VCs, who may not have life science expertise. 
Many VCs purposely avoid life sciences because of these myriad challenges.
IPOs and Acquisitions. Regardless of what is easy versus what is difficult, VCs will “fol-
low the money” because that is their job. VCs must exit their deals and maximize returns 
on their investment. The data for Initial Public Offerings (IPOs) and Acquisitions were 
examined to determine which companies are giving VCs their best exits.
In 2012, IPO data show that:
• 4 Media and Entertainment companies brought in a whopping $16.2B;
• 15 Software and IT service companies brought in $2.7B;
• 13 Biotech and Medical Device companies brought in just under $1B; and
• 3 Industrial and Energy companies brought in about $250M.
In 2012, Acquisition data show that:
• 202 Software and IT Services companies were sold for a total of $7.2B;
• 59 Biotech and Medical Device companies were acquired for $4.4B;
• 43 Media and Entertainment companies were acquired for $2.3B; and
• 31 Industrial and Energy companies brought in $1.1B.
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These results are summarized in Figure 3.6, which shows that the easier opportunities in 
IT and Creative & Commerce are bringing in four times as much in returns as the harder 
opportunities in the Life and Physical Sciences. It is no surprise that the VC industry is 
trending as it is, and it is possibly unlikely that this trend will change anytime soon.
Industry Group Information Technology
Creative & 
Commerce Life Sciences Physical Sciences
IPO $2.7 B $16.2 B $1.0 B $0.3 B
Aquisition $7.2 B $2.3 B $4.4 B $1.1 B
Total $28.4 B $6.7 B
Figure 3.6: IPOs & Acquisitions, Total Returns by Industry
Section Summary. In this section, the data has shown that the Internet plays a dominant 
role in VC investing, and that dominance also extends to the other Creative & Commerce 
industries, especially Media and Entertainment companies.
What is of significance is that upon a more thorough analysis, 2012 data indicate:
• 59% of all investments were Internet related; and
• 73% of all initial investments were Internet related.
These statistics are depressing for Life and Physical Science start-up companies that have 
no application to the Internet.
As will be observed in a following section (and albeit with many goals other than eco-
nomic development), the U.S. government continues to pour billions of dollars into hard 
science research in all fifty states. Yet, a hard science company with no application to the 
Internet and which is not based in California or Massachusetts has a slim chance of getting 
any kind of VC investment to move forward.
Even though a Section Summary has already been provided, there is still one question that remains 
unasked about Internet investment. Where is Internet investing occurring? 
Internet Investment by State. Again, the top three states, California, Massachusetts, and 
New York, are shown in Figure 3.7. What is interesting here is that, in this one category, 
New York has surpassed Massachusetts. Indeed, a major report was published recently indi-
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cating that New York City has become a digital media mecca and has surpassed Boston in 
that realm.5 Of course, California still dominates by a long shot.
Figure 3.7: Internet Investing by State, 2008-2012
In this discussion of Internet investing in New York, a question could arise as to upstate’s 
participation in this activity. Had this question been addressed by adding bars to the 
graph shown in Figure 3.7 for upstate, they would have essentially been invisible. The 
lack of upstate’s participation means that when investing in New York is being discussed 
for Internet deals, it is clear that “New York” really means New York City. Upstate New 
York is hardly a blip on the radar for these investments.
So, an additional statement can be added to the Section Summary, which is that NY, which 
has been trailing behind California and Massachusetts in every category up until now, 
now surpasses Massachusetts for Internet investing (although California still dominates). 
The Internet and other digital technologies dominate in NYC.
5 “New Tech City,” Center for an Urban Future, May 2012.
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V. Venture Capital in New York
While looking at the national context of VC investing patterns and favored industries is 
interesting and important, this project is fundamentally about New York State and that 
focus must be maintained in compiling information that might be helpful to the successful 
expansion of New York’s innovation economy. Therefore, in this next section, the focus 
centers just on New York.
Funding for New York State. It was previously determined that for the last five years, 
New York State has received on average 6% of the national total, even though it ranks as 
the third highest state for venture capital. Figure 4.1 shows the actual amounts broken 
out from 2008-2012. VC funding is market sensitive, and in New York State, it has ranged 
from $1.1B to $2.5B over the last five years, averaging $1.7B per year.
While the data are compiled for the state, it is important to look more granularly to recog-
nize, that as shown in Figure 4.1, almost all of this VC funding is going to New York City.6
Figure 4.1: VC Investments, NYS, 2008-2012
Every year, upstate New York receives about 3-4% of the state’s total investment, essen-
tially a negligible amount. While investments downstate are increasing, upstate New York 
is terribly overshadowed and/or overlooked by investors. In the best year, 2011, upstate 
received $106M, but in a low year like 2009, the entire upstate area received only $28M.
6 Note that the NVCA/www.pwcmoneytree.com data does not break out Long Island as a separate region, 
so in this report, all data for Long Island is aggregated with, and attributed to, New York City.
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Who’s Investing in New York State? Previously it was determined that New York City 
VCs deploy about $2B annually, but only 17% (or about $350M) remains in-state. That is 
about 21% of the total that is received by New York. Where is the rest coming from?




Rest of Country $368 22%
Undisclosed $265 16%
Foreign $114 7%
Total Received $1,654 100%
 Figure 4.2: Where New York Money Comes From
Even though California VCs only send 4% of their monies to New York, it does appear 
that they are matching the New York City VCs’ commitment to New York with about 
$330M. The rest comes from “all over.”
Funding by Industry, New York State. Funding, broken out by industry, is where the real 
story emerges for New York State. The blue bars in Figure 4.3 indicate overall funding. 
But notice both green bars. The darker green is for IT, definitely a favored industry in New 
York State. The lighter green bars are for Creative & Commerce, also definitely favored 
industries. And actually in 2011 and 2012, Creative & Commerce garnered more invest-
ment capital than even IT.
Figure 4.3: VC Investments by Industry, NYS, 2008-2012
In contrast are the red and pink bars: Life Science investing is decreasing, and the small 
attention it is receiving stands in sharp contrast to IT and Creative & Commerce. The story 
is the same for the Physical Sciences.
Granular Look. Because this situation is so important to fulfill the hope of successfully 
commercializing university-based technologies, it is worth taking a granular look at each 
of these industry segments with exact percentages from 2008 to 2012.
$M
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Figure 4.4 shows that IT has long been a favored industry in New York State. If anything, 
its popularity seems to be increasing in recent years. A major peak in 2010 was observed, 
when IT consumed 52% of total investments. The average number of deals per year was 
126, and the average deal size was $5.4M.
 
VC $M 2008 2009 2010 2011 2012 
NYS Total $1,513 $1,068 $1,401 $2,429 $1,853 
Information Technology 39% 41% 52% 37% 41% 
Creative & Commerce 28% 34% 32% 46% 44% 
Life Sciences 17% 12% 6% 8% 8% 
Physical Sciences 16% 13% 10% 9% 7% 
Figure 4.4: VC Investments by Industry, in Percentages
Creative & Commerce have also long been favored industries in New York State. Again, 
if anything, their popularity seems to be increasing in recent years. A major peak in 2011 
was observed, when Creative & Commerce investing exceeded $1B, or 46% of total invest-
ments. The average number of deals per year was 105, and the average deal size was 
$6.0M.
Life Sciences has not been a favored industry in New York State, and its popularity seems 
to be decreasing in recent years. A new low in 2010 was observed where Life Science 
investing dropped to $81M, or 6% of total investments. The average number of deals per 
year was only 21, and the average deal size was $7.4M, actually a bit larger than IT and 
Creative & Commerce deals.
Physical Sciences has also not been a favored industry in New York State, and its popular-
ity is also decreasing. A new low in 2012 was observed where Physical Science investing 
dropped to $124M, or only 7% of total investments. The average number of deals per year 
was 35, and the average deal size was $4.9M, the lowest deal size compared to the other 
industries.
VC Investing by Industry, 2012. Focusing on 2012, the data in Figure 4.4 can be reconfig-
ured in the form of a pie chart. The visualization of what is happening in New York is 
dramatic. The overall investing pattern is not consistent with national averages (Figure 
4.5) and is unique to New York (Figure 4.6).
IT investing is much more popular in New York than most New Yorkers probably realize. 
What is really surprising is that Creative & Commerce investing is now exceeding IT. No 
other venture pie in the world has Creative & Commerce at 44%. Of course, this category 
includes the legacy industries in New York City, considered one of the most creative cities 
in the world and the world’s capital for commerce. While this investment pattern makes 
perfect sense, these numbers are not common knowledge even in the New York entre-
preneurial community. Certainly no one has yet recognized, in numbers, that the hard 
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sciences are being marginalized in this way. These data may have profound implications 
for how structures are implemented to grow the innovation economy in New York State.
Figure 4.5: VC Investments by Industry, USA, 2012
Figure 4.6: VC Investments by Industry, NYS, 2012
Funding by Stage. A look at funding by company development stage is also important. 
Figure 4.7 shows funding by stage, which is again significantly different for New York 
than for the rest of the country. Recalling the bar graph for the U.S. shown earlier in Figure 
2.8, a trend was observed in that investing was almost 1/3, 1/3, 1/3 for early, expansion, 
and later stage companies. That is not the pattern here.
In New York State, in 2008, it almost looked like 1/3, 1/3, 1/3, but the trend has moved 
dramatically to expansion as the favored stage for investors. Seed-stage funding by VCs 
continues to be at a very low level. This is crucial to note. Internet companies require only 
small amounts of seed capital to launch. In conjunction with angel monies, a small amount 
of venture capital might be sufficient to foster the recent success in New York City. But for 
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hard science start-ups, large amounts of cash are needed even at the seed stage and this 
low level of seed activity is not enough to bring companies through the Valley of Death.
$M






Figure 4.7: NYS Funding by Stage, 2008-2012
Section Summary. New York State has received, on average, $1.7B annually in VC invest-
ments in the last five years. A woefully small amount (3%, or around $50M) has gone to 
upstate, so clearly the monies are really for New York City. On average, 21% has come 
from in-state VCs, a similar amount from California, and the rest from elsewhere. Forty-
six percent of the investing has been in expansion stage companies. The real story is in the 
industries receiving capital: an amazing 85% is being committed to the digital technolo-
gies and only 15% goes to the hard sciences. Again, the investing excitement over digital 
technologies is in New York City, while upstate does not even appear to be on the radar 
for these industry sectors.
All these trends could mean that, every year, the chances of a seed stage life science com-
pany in upstate receiving capital from a New York City VC is: $1.7B (NYS total) x 21% 
(from NYC) x 8% (to life sciences) x 3% (to Upstate) x 3% (to seed stage) = almost zero. The 
chances are even worse for a physical science company, and the odds are also not good 
for science companies of either type in New York City.
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VI. Academic R&D Expenditures
At this point, the reader should have a thorough understanding of venture investing pat-
terns nationally and in New York State. But venture capital supports the translation of 
academic R&D into viable companies (at least that is the working premise here), and a 
thorough understanding of academic R&D nationally or in New York State has not yet 
been provided. This section examines those data.
Figure 5.1: National University R&D Expenditures
University R&D, Nationally. Very much in contrast to venture capital investments that 
are subject to market variability, university-based R&D funding, primarily supplied by 
the federal government, is subject to federal agency dynamics, political pressures, and the 
interests of academic scholars. Expenditures rise steadily each year seemingly indepen-
dent of market conditions. As shown in Figure 5.1, nationally, R&D investing was at about 
$50B in 2008, and by 2011, it was already at about $65B. This represents a 30% increase in 
four years.7
With this $65B, universities performed more than half of the nation’s total academic 
research. The other half was conducted at federal laboratories, non-university affiliated 
medical facilities, and other research institutions. Total academic research exceeds well 
over $100B annually, representing a significant portion of total U.S. R&D.
The federal government provides the bulk of these funds. Six agencies provide almost all 
federal support—the National Institutes of Health, National Science Foundation, Depart-
ment of Defense, National Aeronautics and Space Administration, Department of Energy, 
and Department of Agriculture.
Top States’ Five-year Trends. Figure 5.2 shows the university-based R&D expenditures of 
some of the top states. California has historically held and continues to hold the number 
7 While there is a year lag at the NSF in reporting R&D numbers and 2012 data is not yet available, we can 
probably expect that the national R&D total for 2012 might be around $68B.
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one position. New York has historically held and continues to rank number two, followed 
by Texas, Maryland, Pennsylvania, and Massachusetts, in that order.
Figure 5.2: R&D Expenditures, by State, Five Year Trends
Top States’ 2010 Snapshot. Using 2010 as a representative year, Figure 5.3 shows the spe-
cific amounts of R&D expenditures for each of the states along with their percent of the 
nation’s total.
Rank Division and State 2010 R&D ($M) Percent
1 California $7,831 13%
2 New York $4,951 8%
3 Texas $4,418 7%
4 Maryland $3,139 5%
5 Pennsylvania $3,127 5%
6 Massachusetts $2,750 4%
Rest of Country $35,019 57%
Total $61,235 100%
Figure 5.3: R&D Expenditures, by State, 2010
$K
27
With these data points, another one of Governor Cuomo’s Troubling Tech Transfer Facts 
can now be updated:
• In 2007, New York universities ranked second nationally in total research 
spending with nearly $4B expended annually; California ranked first with 
$6.5B.
• In 2011, New York universities ranked second nationally in total research 
spending with $5.3B expended annually; California ranked first with $8.2B.
• In 2012, expenditures in New York can be estimated to be over $5.5B, and 
California expenditures at about $8.5B.
States with >$1B in R&D. The national R&D statistics stand in sharp contrast to the ven-
ture capital data. Venture capital is highly concentrated in California, Massachusetts, and 
New York, while the nation’s intellectual capital and research expertise is much more 
broadly distributed. In fact, there are 20 states that expend at or over $1B annually in R&D 
just at their universities.
For those researchers/entrepreneurs who are not in California, it is unfortunate that over 
50% of all venture capital dollars goes to California, when so much “leveragable” intel-
lectual capital and high-level university-based research resides in and is well distributed 
throughout the entire U.S.
New York State Five-year Trends. Figure 5.4 is a bar graph that shows five-year R&D 
trends and a steady increase in expenditures in New York State. As already noted, in 2010 
R&D levels nearly hit $5B and have now exceeded that.
Figure 5.4: R&D Expenditures, NYS
Including Brookhaven National Lab on Long Island, which expends another $650M annu-
ally, the New York State total for research funding stands at or over $6B annually. That is 
a huge investment in basic research. And again, it ticks up year after year.
Upstate-Downstate Split. Given these high expenditures, how are they divided between 
upstate and downstate? The answer is: very evenly. Figure 5.5 uses 2010 as a representa-
tive year, but any year could have been used. The balance every year is nearly 50:50 with 
downstate always slightly over 50% and upstate slightly under 50% (although adding 
in Brookhaven tips the balance in downstate’s favor). But regardless, at number two in 
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the nation for R&D, this is a very smart state, and its intellectual strength is quite evenly 
distributed.
Figure 5.5: NYS R&D Expenditure Split, 2010
Top Research Universities. Figure 5.6 shows New York’s top research universities and their 
specific expenditure levels. Only universities exceeding $70M annually were included on 
the list. Columbia and Cornell lead the pack with over $800M and $750M, respectively.
 
Rank Top Research Universities  2010 R&D  
Expenditures ($K) 
1 Columbia U $807,235 
2 Cornell U $749,721 
3 U of Rochester $414,655 
4 Mt. Sinai School of Medicine $370,666 
5 NYU $365,944 
6 SUNY Albany $359,364 
7 SUNY Buffalo $349,670 
8 Yeshiva U $314,240 
9 Rockefeller U $265,750 
10 SUNY Stony Brook $204,728 
11 Syracuse U $107,024 
12 Rensselaer Polytechnic Institute $83,952 
13 SUNY Binghamton $72,057 
Total for these 13 Universities $4,465,006 
% of State Total 90% 
15 schools at $10-50M each, totalling … $395,086 
51 schools at $100K to $10M each, totaling … $90,901 
Total for NYS $4,950,993 
 Figure 5.6: Top Research Universities in NYS
These thirteen institutions represent 90% of the state’s total expenditures. Fifteen other 
universities share another 8% of the total by expending between $10M and $50M annually 
in R&D, and 51 smaller schools share in the final 2% with between $100K and $10M in 
R&D annually each.
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Upstate-Downstate Split. Figure 5.7 categorizes the universities as upstate or downstate. 
Upstate has four major players in Cornell, University of Rochester, the University at 
Albany, and the University at Buffalo, with Syracuse University, RPI, and Binghamton 
University still making the top list but with smaller contributions.
Downstate has six major players as listed, with a large gap between them and the smaller 
schools, all coming in at less than $70M each.
 Top Universities, Upstate 2010 R&D  Expenditures ($K) Top Universities, Downstate 
2010 R&D  
Expenditures ($K) 
Cornell U $749,721 Columbia U $807,235 
U of Rochester $414,655 Mt. Sinai  $370,666 
SUNY Albany $359,364 NYU $365,944 
SUNY Buffalo $349,670 Yeshiva U $314,240 
Syracuse U $107,024 Rockefeller U $265,750 
RPI $83,952 SUNY Stony Brook $204,728 
SUNY Binghamton $72,057 
Total for 7 Universities $2,136,443 Total for 6 Universities $2,328,563 
% of State Upstate Total 91% % of State Total 90% 
Others at less than $70K $213,466 Others at less than $70K $272,521 
Total for Upstate $2,349,909 Total for Downstate $2,601,084 
Figure 5.7: Top Research Universities in NYS, split Upstate, Downstate
Regional Breakdown. For those who view the state as segregated into ten regional coun-
cils, Figure 5.8 provides data. Mid-Hudson, North Country, and Mohawk Valley are the 
only regions that lack the major university powerhouses that the other regions enjoy.
Figure 5.8: University R&D, split by 10 Regional Councils
R&D by Industry/Sector. Unusual patterns for New York State start to emerge when look-
ing at the breakdown of R&D by industry/sector.
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Nationally, over the last twenty years, the distribution of academic R&D expenditures 
across the broad scientific fields has shifted in favor of Life Sciences and away from Physi-
cal Sciences. As shown in Figure 5.9, the Life Sciences now represent the largest share 
(well over 50%) of expenditures in academic R&D. However, in New York State, Life Sci-
ences represent 65% of the total. The New York State pie is skewed because of downstate 
New York, where academic research is fully three-quarters in Life Science fields.
Figure 5.9: University R&D, by Industry/Sector
Specifically, downstate Life Science research is at 76% of the downstate total. This is the 
strongest imbalance toward Life Sciences in the nation. New York City’s Life Science clus-
ter includes nine major academic institutions. In addition, there are 26 additional research 
facilities and medical centers and 58 hospitals. NYC was the second largest recipient of 
NIH funding from 1999 through 2008. Relative to Life Science research, upstate is more 
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typical at 52%, as is California at 59%. Massachusetts’ university R&D is well balanced at 
44% for Life and 43% for Physical Sciences.
Figure 5.10: University R&D, by Industry/Sector
Section Summary. While venture capital is subject to market pressures, university-based 
R&D is subject to political factors and the interests of researchers and increases annually 
at a fairly steady rate. Levels are now topping $65B annually for the nation and over 
$100B, if federal labs are included.
New York State ranks number two in the nation, second only to California, expending 
well over $5B annually at its universities (nearly twice that of Massachusetts) and about 
$6B when Brookhaven is included. It also hosts other prestigious research institutions 
such as Roswell Park and Sloan Kettering Cancer Institutes, which further increase total 
academic R&D spending.
R&D expenditures are divided almost evenly between upstate and downstate, with Life 
Sciences as a dominant industry/sector, particularly downstate.
What’s Next? A working premise here is that venture capital is required to translate aca-
demic R&D into viable companies.
• A thorough understanding of venture investing patterns has been provided.
• It has been shown that academic R&D is well funded both in the U.S. and in 
New York State.
• If the reader correctly understands the data already provided, suspicions may 
be rising that the interests of VCs and academic researchers are increasingly 
misaligned.




U.S. R&D vs. VC, juxtaposed. In this section, the VC and R&D data is directly juxtaposed 
to determine how well the interests of the VCs and the academic researchers correlate. 
Using 2010 as a representative year, the R&D and VC numbers are broken down by indus-
try sector. As below, the mismatch between R&D spending and VC investing in the U.S. is 
illustrated with the data placed side-by-side. Note especially the life science bars.
Figure 6.1: US R&D vs VC, 2010
New York State R&D vs. VC, juxtaposed. The mismatch appears to be particularly dra-
matic in New York State. As shown below, in 2010, New York expended $5B annually for 
university-based hard science research, with ~65% invested in Life Science. Meanwhile, 
venture capital investing in New York is largely ignoring the hard sciences, especially the 
Life Sciences, and favoring Information Technology.
Figure 6.2: NYS R&D vs VC, 2010
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Upstate New York R&D vs. VC. Again, with 2010 as a representative year, the well-known 
and discouraging story for upstate New York is that VC is literally invisible—i.e., it’s not 
there. However, the university R&D expenditures are strong, among the highest in the 
nation. The economic developers in the region are pinning their hopes on biotech as the 
future of the Upstate economy. It is difficult to know how that is going to happen with 
almost no venture interest.
Figure 6.3: Upstate NY R&D vs VC, 2010
Downstate New York R&D vs. VC. 2010 is still the year, but now the focus is on downstate 
New York, where VCs don’t look interested in the Life Sciences either. In fact, we could 
probably state that the Life Sciences are being ignored and the favored industries are again 
IT (by far) and Creative & Commerce.
Figure 6.4: Downstate NY R&D vs VC, 2010
Massachusetts R&D vs. VC. A comparison can be made between downstate New York 
(basically New York City) to Massachusetts (basically Boston). The bars in Figure 6.5 indi-
cate a different world in Boston. The reader might consider the question: Would a life 
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science company prefer to launch in Boston or NYC? Or actually, what would the preference 
be for any kind of university start-up besides IT?
Figure 6.5: Massachusetts R&D vs VC, 2010
California R&D vs. VC. When launching a science start-up, the odds of receiving capital 
are much more favorable in California than in New York. IT is very popular for investors 
in California, but the Physical Sciences attract significant venture investment as well. Life 
Sciences are down a bit. 
Figure 6.6: California R&D vs VC, 2010
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It’s Getting Worse. This report is raising concerns about venture investing patterns rela-
tive to the Life Sciences. An article appeared recently, reporting that the situation relative 
to life science investing may be getting worse.8
Upstate Perceptions. Given the data shown in Figure 6.3, it is ironic that there is a percep-
tion in upstate New York that the region’s future economic strength lies in the Life Scienc-
es. The following excerpt is taken from a Zogby Survey of upstate New York employers 
and shows that “life sciences and high technology are seen as having the highest potential 
for job creation” in the region.9
8 www.pharmalive.com/life-sciences-vc-funding-took-double-digit-dip-2012
9 Zogby Survey of Upstate NY Employers, John Zogby of Zogby International, March 2013, commissioned 
by The Buffalo Niagara Partnership.
The results from the Zogby poll shown indicate that among all the industries listed, the high-
est percentage of all respondents stated that the Life Sciences would have the highest rate of 
growth for job creation and private sector investments in upstate NY.10
Not to burst anyone’s bubble, but it is difficult to know how that is going to happen with the 
current patterns in VC investing as they are and as observed in this report.
Section Summary. There is a very positive perception that the future economic strength of New 
York State (at least upstate) depends on developing the Life Sciences and that somehow the 
region will attract private sector investments. This could be a logical thought since, as in Califor-
nia and Massachusetts, the majority of New York’s university R&D is focused on Life Sciences. 
But in New York, venture capital is almost exclusively focused on digital technologies while the 
hard (both Life and Physical) sciences are being ignored. This mismatch, or disconnect, must be 
given serious consideration if our plans for economic success are to be realized.
10 Zogby Survey of Upstate NY Employers, John Zogby of Zogby International, March 2013, commissioned by The 
Buffalo Niagara Partnership.
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VIII. Observations and Comments
The very good news of this study is that while maintaining a strong position as second 
in the nation in terms of university-based R&D expenditures, New York State has greatly 
improved its position as a recipient of investment funds to support entrepreneurship. This 
phenomenon is entirely led by New York City, whose innovation ecosystem has under-
gone astonishing growth over the past five years. The challenge within this good news is 
that the growth in New York City has been almost exclusively in the Internet sector, not 
in the commercialization of R&D. The challenge for the rest of the state, and upstate in 
particular, is that they have participated hardly at all in this growth.
Thus, active pursuit of an innovation agenda for New York State is smart and timely. Yet, 
there are nuances within the entrepreneurial ecosystem that if not addressed and accom-
modated could potentially short-circuit these efforts. More than a nuance, as reported in 
this paper, is a lack of alignment between venture capital and academic R&D in New York 
State, in both type and quantity. Understanding this misalignment is key to driving policy 
that will be both responsive and effective.
One outcome of this misalignment is the scarcity of thriving innovation-based entrepre-
neurial firms, especially in upstate New York. Given New York’s large pool of intellectual 
property created through university research, it is easy to imagine that better “technology 
harvesting” will increase the economic yield. It is a real challenge, though, for such com-
panies to grow without available investment capital to provide both financial support and 
the many intangibles that venture capitalists provide to help nascent companies grow.
Growing a successful innovation ecosystem in upstate New York is not just a matter 
of better technology transfer. With so much of the intellectual property in the Life and 
Physical sciences, a formula for profitable companies will require significant time and 
adequate investment capital. As this report shows, investment capital is hardly available 
at all for this task. Life science investment requires a great deal of domain knowledge, in 
addition to the particular patience required due to the regulatory steps required. While 
public funds perform an important function priming the pump, new investors must also 
be identified and attracted to become engaged in New York State.
It must be understood that not all “tech” is the same. This report offers a distinction between 
“soft” and “hard” tech that may be useful. Hard tech is literally harder to advance given 
the greater complexity and challenges of developing science into technology, refining 
technology into products, and testing those products while maintaining a clear sense of 
the market. Such opportunities require investors who are not only patient, but also have 
some knowledge of the more complex domains involved. Very different is “soft tech,” 
which generally relies on digital or Internet-based technology that is well understood, 
and whose major challenges have to do with application, market savvy, and execution. 
These latter areas are less expensive to fund, and are generally easier for an intelligent 
non-expert to understand.
New York City is capitalizing on its strengths in soft tech. Its huge customer base, global 
reach, and most importantly, its domain expertise in fields as diverse as finance and 
fashion, make it a likely leader in this space. This is very timely for the New York City 
economy, its entrepreneurial community, including its investors. As a result, hard-tech 
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entrepreneurship both downstate and upstate has been marginalized. This is consistent 
with what appears to be a growing mismatch between the interests of university research-
ers and VCs nationally, but the misalignment is particularly dramatic in New York. 
New York City will hopefully sustain its entrepreneurial momentum as its entrepreneurs 
continue to create innovative digital capabilities around its legacy industries in creative 
(media, entertainment, advertising, fashion, education) and commerce (finance, business, 
retail, distribution). However, upstate’s strengths, clusters, university R&D, and legacy 
industries are all in hard sciences. Legacy industries include optics, photonics, electron-
ics, instrumentation, biotech, medical devices, computer hardware, etc. At this point, its 
entrepreneurial ecosystems are “invisible” to VCs and struggling.
In conclusion, this report offers a challenge, an opportunity, and a consideration of actions 
for the road ahead.
The Challenge. Improving the performance of the New York State innovation ecosystem, 
especially upstate, to successfully commercialize its technology into vibrant, meaning-
ful firms will require stronger, and perhaps new, ecosystems of investors and others to 
create and grow businesses built on Life and Physical Sciences. The current gap between 
investors and academic researchers may require creative actions, for instance, engaging 
investor communities in Massachusetts, California, and elsewhere.
The Opportunity. The success of the New York City paradigm in growing many entrepre-
neurial businesses over the past five years, without significant contribution from university 
R&D, must be explored for its potential economic benefit upstate. START-UP NY offers 
the opportunity for many kinds of university-business alliances to form, other than those 
based on the hard sciences. Engaging New York City business leaders in designing mutu-
ally beneficial partnerships to grow opportunities upstate based on this model seems an 
obvious step to explore.
The Road Ahead. The Entrepreneurship in New York project is committed to supporting 
a vibrant entrepreneurial ecosystem and a strong innovation economy across New York 
State. It is designed to tackle multiple goals and disseminate analytical findings by issuing 
a series of reports.
The next report will provide a baseline assessment of university-based entrepreneurship 
using specific metrics, including number of university spin-outs, sector performance, 
regional performance, and economic impacts. Future reports will measure the success of 
current initiatives to stimulate the translation of innovation into commerce. These reports 
are intended to serve as a baseline against which progress of New York’s innovation 
agenda can be measured.
Collectively, the ENY project reports will deepen the knowledge base of regional stake-
holders so they can respond creatively and actively to the challenges and opportunities in 
the global economy and spur innovation and entrepreneurship in New York State.
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Appendix A: Summary of Misalignments
The Misalignments between Venture Capital and University-
Based R&D: A National Look




Expenditures, mostly from the federal 
government, are now topping $65B 
annually for the nation and are over $100B if 
spending at federal labs is included.
Subject to market pressures and can be 
variable; VC’s are currently investing 
about $30B annually on start-ups.
Spending on 
Hard Sciences
The federal government continues to 
increase spending almost exclusively in the 
hard sciences.
In recent years, VC investing in the 
hard sciences has declined steadily.
Geographic 
Distribution
Conducted to a significant extent in every 
state in the country. There are 20 states 
that expend at or over $1B annually, and 
even more states join the list if spending at 
federal labs is included. But the majority of 
these states are in VC “fly over zones”.
Highly concentrated in three states, 
California, Massachusetts, and New 
York; most states have little access to 




The conversation about accelerating the 
commercialization of university-based 
research is happening in nearly every state 
in the US because nearly every state has 
major universities and/or federal research 
facilities and has an interest in capitalizing 
on its hard science research and creating an 
innovation economy.
A stong historical focus on IT, 
software, and the internet. Within the 
last five years, the trend has intensified 
and the majority of VC investments are 
now being made in IT and Creative & 
Commerce (as these later industries 
become digital and mobile).
Needs
30 million people die annually from 
disease; the US continues to seek 
energy independence; the military must 
continuously upgrade and advance its 
weapons systems. Federal and state 
governments understand these NEEDS and 
are committed to supporting the research in 
the hard sciences at universities across the 
country where technologies to solve these 
problems are being developed.
VCs NEED to get a return on their 
investment (ROI). If they are getting 
returns with companies in software/IT/
internet, then that is what they need to 
focus on. If the market is demanding 
these products and services, then that 
is where the VCs will place their bets.
Translational 
Efficiency
According to the Global Innovation Index 
2012, the USA is #10 worldwide for R&D
According to the Global Innovation 
Index 2012, the US ranks #70 for 
“translational efficiency”.
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The Misalignments between Venture Capital and University-
Based R&D: A Focus on New York State
Variables University-based R&D Venture capital
NYS Leads in 
Academic R&D 
but Lags in 
Venture Capital.
NYS is #2 in the nation. There are 13 
major research universities, expending 
from $70M to $800M annually in R&D, 
totaling well over $5B. Adding in 
Brookhaven National Labs, brings the 
total to about $6B annually!
Relative to California and Massachusetts, 
NYS doesn’t receive that much, doesn’t have 
that much under management, and doesn’t 
keep as much in-state. NYS has about 6% of 
the national total, meaning that on average 
NYS receives about $1.7B per year.
Geographic 
Distributions.
Well balanced between Upstate 
and Downstate; Upstate invests 
about $2.3B annually (nearly the 
same as the state of North Carolina) 
and Downstate invests about $2.6B 
annually
Downstate, particularly NYC, receives 97% 
of the venture capital in the state while the 
entire Upstate region receives 3%. Upstate 
NY is a venture capital desert.
Hard Sciences 
Downstate
Of the $2.6B in Downstate R&D, 76% 
of all R&D Downstate is in the Life 
Sciences and 13% is in the Physical 
Sciences
Of the nearly $2B in venture capital in NYC, 




Of the $2.3B in Upstate R&D, 52% of 
all R&D Upstate is in the Life Science 
and 32% is in the Physical Sciences
There is extremely little VC investing 
Upstate in either the Life or Physical Science, 




Only 4% of Downstate university 
R&D expenditures are in IT, and 
essentially none in Creative and 
Commerce
In recent years, NYC has become a “digital 
media mecca”. NYS/NYC now exceeds 
Massachusetts/Boston is investing in the 
internet and other digital technologies. 
In 2012, 41% of the venture capital was 
committed to IT opportunities and 44% went 




As at Downstate universities, only 
4% of Upstate R&D expenditures are 
in IT, and essentially none in Creative 
and Commerce
Upstate entrepreneurs are really not involved 
in the Creative & Commerce industries 
and almost no investments are being made 





University R&D expenditures are not 
being matched to VC investments in 
NY.
California and Massachusetts R&D 
expenditures are better matched to their VC 
expenditures. More goes to the hard sciences 
and much less goes to Creative & Commerce.
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Appendix B: Methodology
Multiple Methodologies. As its name implies, the Entrepreneurship in New York project 
is intended to study many aspects of entrepreneurship in the state of New York, particu-
larly university-based entrepreneurship, through the application of several methodolo-
gies, including:
1.  Defining, collecting, and analyzing relevant metrics from primary data 
sources, such as university technology transfer offices and university-based 
spin-outs;
2.  Reviewing and summarizing key findings from predecessor reports that also 
address aspects related to New York State entrepreneurship;
3.  Carefully sorting, analyzing, and benchmarking data from highly regarded 
and reliable publically available sources on matters such as venture capital 
investments and academic R&D expenditures; and
4.  Conducting interviews and focus groups with representatives from myriad 
stakeholder organizations regarding their views on the interpretation of the 
data, personal perspectives on the subject, and anecdotal experiences.
All of these methodologies will be brought to bear while progressing through the ENY 
project and issuing reports. This report, however, was primarily focused on the third 
methodology cited above. The focus was on collecting and analyzing hard data from 
publically available sources to provide an objective assessment on the status of venture 
capital investments and R&D expenditures in New York State. Publically available data 
on national matters of interest is particularly useful in benchmarking New York against 
California and Massachusetts. There is assurance that we are reliably comparing “apples 
to apples” and that selected metrics are not being interpreted differently from state to 
state. Also the use of hard data is unrelated to anyone’s opinion but is merely a presenta-
tion of numbers. While implications can be discussed, the numbers being provided by 
publically available sources do not carry with them an associated bias.
Venture Capital Data. All venture capital data in this report was derived from the publi-
cally accessible searchable database at www.pwcmoneytree.com, as well as the National 
Venture Capital Association (NVCA) Yearbooks from 2008 through 2013, which are all 
downloadable online.
The NVCA collects and analyzes venture capital fundraising, investing, and exit statistics 
in conjunction with its research partners PricewaterhouseCoopers and Thomson Reuters. 
NVCA/PWC/Reuters is regarded by the venture capital community as one of the most, if 
not the most, comprehensive and accurate source for all venture capital and private equity 
investment information.
Through many hours of tedious labor, the data in this report was sorted from the PWC 
online data base by state, by industry, by stage, and by year and then reconfigured in 
many different ways into all the data tables appearing in Sections III, IV, and V. The 
annual NVCA reports were particularly helpful, and served as the primary source, for 
assembling information related to internet-investing. Other than calculating an average 
there was no need to apply any complicated mathematical or statistical analysis methods.
Academic R&D Data. All data pertaining to academic R&D in this report was derived from 
the National Science Foundation (NSF) Higher Education Research and Development (HERD) 
Reports from 2008 through 2011, which, like the NVCA reports, can all be downloaded online. 
The HERD Survey collects information annually from nearly a thousand research-performing 
academic institutions on R&D expenditures by academic field, as well as by source of fund and 
is the primary data source for these expenditures in the U.S. and outlying areas.
As with the VC data, the R&D data presented here was sorted from the downloaded databases 
by state, by region, by industry/sector, and by year and then reconfigured in many different 
ways into all the data tables appearing in Section V.
Matching VC and R&D Data. The intent in this report was to “match up” venture capital invest-
ment with R&D investment to determine if there was alignment or misalignment between the 
interests of VCs and university-based researchers. To do that, it was necessary to create a com-
mon language between the data sources being used prior to commencement of this project.
The NVCA uses 16 categories to define the investments and deals in the VC community. The 
NSF uses 36 categories to define areas of fundable research being conducted at universities. 
These categorizations were too granular for purposes of the ENY study. For this reason, the 
first step was to create a terminology alignment table that would regroup and reduce the NVCA 
and NSF categories into broad categories. As was apparent throughout this document, the focus 




• Creative & Commerce
The way in which the NVCA and NSF categories were grouped for purposes of this study is 
shown in Figure B-1.
Both the NVCA and the NSF track funding for the Life Sciences, the Physical Sciences, and 
Information Technology. But it is really only the NVCA that tracks investments in the Creative 
& Commerce industries. And it is really only within universities that the social sciences are 
supported with research expenditures as tracked by the NSF.
Other References. Finally, a few other report references where integrated for commentary as 
needed, including:
• Zogby Survey of Upstate New York Employers, John Zogby of Zogby International, 
March 2013, commissioned by The Buffalo Niagara Partnership;
• Global Innovation Index 2012. Ref: www.economist.com /node/21531002; and
• A brief reference regarding VC investing in the life sciences taken from www.
pharmalive.com/life-sciences-vc-funding-took-double-digit-dip-2012.
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There are many other excellent reports that provide significant insights into the status of 
entrepreneurship in New York, and several of these will be referenced in a subsequent 
report.
Figure B-1: Terminology Alignment
ENTREPRENEURSHIP IN NEW YORK:
The Mismatch between    
Venture Capital and Academic R&D
Dr. Judith Albers, the Van Arsdale Chair of Entrepreneurship 
at SUNY Geneseo, and a respected voice in the innovation 
community of upstate New York, was the study’s lead 
researcher. “While the investment dollars in the state have 
increased,” said Dr. Albers, “a more detailed analysis indicates 
that the increase has been focused heavily on ‘soft tech’ in 
New York City.  In comparison, ‘hard tech’ companies in either 
upstate or downstate New York have a much smaller chance of 
securing funds to launch and grow. Start-ups in the life sciences 
face the most serious challenges.”
Co-author Thomas Moebus, Director of Business and Investor 
Development at the Research Foundation for SUNY, said “The 
increase in venture investment in New York City suggests the 
potential for greater links between upstate opportunities and 
New York City investment to fuel entrepreneurial growth in 
fields like IT and services around the state.”
Milne Library  
SUNY College at Geneseo 




The Entrepreneurship in New York study is a joint venture of the SUNY Levin Institute, 
the Research Foundation of SUNY, and SUNY Geneseo. This study shows that New 
York now commands a larger share of national venture investment than in past studies. 
Although, within this picture a significant disconnect is revealed. New York’s strong per-
formance in academic R&D in the sciences stands in contrast with the relatively modest 
amounts of private investment available to move these innovations forward commercially.
In 2012, 85% of the venture capital invested in New York State firms was invested in 
information technology and creative and commerce services, while 15% was invested in 
the life and physical sciences. By contrast, 89% of academic R&D expenditures in New 
York State were in the life and physical sciences, with only small amounts invested in IT.
Authors Judith Albers, PhD, and Thomas R. Moebus feature important data and analysis 
that conclude increased investment in the life and physical sciences are needed. They 
identify specific opportunities for NYC and other investors that emerge as part of START-
UP NY and other state initiatives.
